Omnesys NEST trading platform has a market share of 20% in India. With the acquisition, Thompson Reuters plans to offer a portfolio of integrated solutions for exchange traded instruments to its customers
Information services provider Thomson Reuters has bought Omnesys Technologies Pvt Ltd, a provider of sell-side order management systems (OMS) and high frequency trading solutions for Indian exchange traded instruments. No financial details were provided.
Omnesys sells multi-asset, multi-venue trading system called Omnesys NEST, which has a much smaller market share compared to ODIN software from Financial Technologies. Omnesys NEST is used by more than 200 of the top financial institutions in India as well as by various exchanges as a front office service to their customers. ODIN has a market share of 80%.
"Thomson Reuters is now able to offer a suite of transaction solutions to sell side institutions and exchanges in India, allowing us to seamlessly integrate this capability with our world-class content and technology. Moreover, it provides us with a new opportunity to service the Indian equities market with a powerful combination of desktop content, analytics, feeds and transaction capabilities," said Swarup Choudhury, managing director, India, Thomson Reuters
Thompson Reuters said it will now be offering a portfolio of integrated solutions for exchange traded instruments to its customers aided by the market-leading sell-side order management system and high frequency trading capabilities by Omnesys Technologies along with its own content, analytics, quant and event driven trading infrastructure.
Lupin’s US unit will soon commence marketing the tablets used for the treatment of insomnia characterized by difficulties with sleep onset or sleep maintenance
Pharmaceutical company Lupin Ltd (Lupin), said it received a final approval for its Zolpidem Tartrate extended - release tablets USP 6.25mg and 12.5mg, from the US Food and Drugs Administration (FDA). Lupin’s wholly owned US subsidiary Lupin Pharmaceuticals Inc (LPI) shall commence marketing the product shortly.
Lupin’s Zolpidem CR tablets 6.25 mg & 12.5 mg is the AB rated generic equivalent of Sanofi’s Ambien CR extended-release tablets and is indicated for the treatment of insomnia characterized by difficulties with sleep onset or sleep maintenance.
Sanofi’s Ambien CR extended-release tablets had annual US sales of about $ 366 million as per IMS MAT March 2013 data.
Asia Index, the JV between BSE and S&P Dow Jones aims to an array of indices enabling global and domestic investors to participate in South Asia’s vibrant economies
The BSE (erstwhile Bombay Stock Exchange) and S&P Dow Jones have formed a joint venture, 'Asia Index' to provide an array of indices enabling global and domestic investors to participate in South Asia’s vibrant economies.
In a statement, the Exchange said, “BSE and S&P Dow Jones Indices announced today the incorporation of Asia Index Pvt Ltd, a joint venture company established to calculate, disseminate, and license the widely followed suite of S&P BSE indices”.
The 50-50 partnership would bring together BSE’s closely watched India index suite, which includes the 30-share Sensex, with S&P Dow Jones Indices’ 115 years of experience in publishing transparent and independent global benchmarks.
“It (Asia Index) will bring additional focus to our efforts to serve investors and develop new business in an area of tremendous potential in India and the entire South Asia geography,” Ashishkumar Chauhan, managing director and chief executive of BSE said.
Asia Index aims to provide a full array of indices enabling global and domestic investors to participate in South Asia’s vibrant economies. It would help investors in achieving their financial goals.
“India, as well as all of South Asia and the ASEAN region, is a market of great strategic importance to S&P Dow Jones Indices. We are excited about the launch of Asia Index and look forward to working closely with the BSE to meet the increasing demand of this critical market segment,” Asia Index CEO Alka Banerjee said.
In February, the BSE and S&P Dow Jones Indices had announced a partnership to meet the evolving needs of Indian and international investors through the development of innovative index solutions.